omation mbers - Society for Laboratory Automation and Screening
omation mbers - Society for Laboratory Automation and Screening
omation mbers - Society for Laboratory Automation and Screening
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
WP048<br />
Scott Reeves<br />
REMP USA<br />
150 Hopping Brook Road<br />
Holliston, Massachusetts 01746<br />
scott.reeves@remp.com<br />
Co-Author(s)<br />
Michael Girardi, REMP USA<br />
Carol Homon, Boehringer Ingelheim Pharmaceuticals, Inc.<br />
Thorsten Poetter, Bayer Crop Science AG<br />
Berta Strulovici, Merck & Company, Inc.<br />
Gerhard Mihm, Boehringer-Ingelheim Pharma KG<br />
Tools <strong>for</strong> Sample Management that are Efficient, Versatile, Proven <strong>and</strong> Evolving – REMP Tube<br />
Technologies<br />
High Throughput <strong>Screening</strong> (HTS) has been heralded as the way to develop better drugs faster. <strong>Screening</strong><br />
technologies in drug discovery have recently seen dramatic advances which have led to throughputs of<br />
over 100,000 compounds per assay per day. There has also been an emergence of a plethora of new assay<br />
technologies enabling a greater range of targets to be screened, all of which have helped catapult HTS into ultra<br />
HTS (UHTS).<br />
However, to be successful at drug discovery, the Compound Management operation must be efficient, versatile,<br />
<strong>and</strong> evolving while trying to ensure that their compound libraries are of the highest quality. In the past, the<br />
management of compound collections were per<strong>for</strong>med by groups that were viewed as serving simple dispensary<br />
functions. Investment in this operation was small <strong>and</strong> its role not understood by many in drug discovery<br />
organizations. The importance of the corporate compound collection, often regarded as “the company’s largest<br />
asset” or it’s “crown jewels,” shifted from the collection size being the most important factor to a more balanced<br />
view of the importance of quality <strong>and</strong> quantity. The results of HTS <strong>and</strong> UHTS, as well as the drug discovery<br />
process as a whole, is only as good as the compounds that are delivered <strong>and</strong>, there<strong>for</strong>e, a very important factor in<br />
its relative success or failure. This poster will provide some insight <strong>and</strong> data from several Compound Management<br />
operations that are considered to be efficient, versatile <strong>and</strong> evolving <strong>and</strong> describe how this has been achieved.<br />
WP049<br />
Heidrun Rhode<br />
Friedrich-Schiller-University, Medical Faculty<br />
Institute of Biochemistry<br />
Jena07740 Germany<br />
heidrun-rhode@mti.uni-jena.de<br />
Co-Author(s)<br />
M. Schulze, G. A. Cumme, A. Horn, Simon Renard, <strong>and</strong><br />
Thomas Moore, Friedrich-Schiller-University, Medical Faculty<br />
Peter Zimmermann, CyBio AG<br />
Multichannel HTS/ µHTS Liquid H<strong>and</strong>ling Systems – Check Using Two-Indicator Systems<br />
Multichannel HTS/µHTS liquid h<strong>and</strong>ling systems have to be checked under conditions close to the screening<br />
reality, i.e., with commonly used sample solutions <strong>and</strong> employing microplate technology. We propose a simple<br />
method to determine precision <strong>and</strong> accuracy of multichannel liquid h<strong>and</strong>ling systems using a combination of<br />
gravimetric <strong>and</strong> optical measurements. The precision of the optical signal is improved by multi-wavelength<br />
measurements using two indicators <strong>and</strong> buffers with low temperature dependence of pH. Factors causing nonlinearity<br />
between the sample volume delivered into a well <strong>and</strong> the optical signal are considered. The resolution<br />
of the method i.e., the imprecision of the measuring system as determined by the imprecision of the signal of a<br />
homogeneous solution with two indicators is better than 0.3% CV <strong>and</strong> 2% CV using absorbance <strong>and</strong> fluorescence<br />
measurements, respectively, suggesting that absorbance measurements should be preferred. The gravimetrically<br />
determined inaccuracy is less than 0.5% CV. The suitability of the method proposed is demonstrated with two<br />
liquid h<strong>and</strong>ling devices using different ejection principles, with commonly used fluids, with 96, 384 <strong>and</strong> 1536<br />
microplates, <strong>and</strong> with photometric <strong>and</strong> fluorimetric indicators. Despite the substantial improvement of fluorescence<br />
signals by multi-wavelength measurements, fluorimetry still tends to overestimate the imprecision of a liquid<br />
h<strong>and</strong>ling system. Imprecisions obtained with optimized methods <strong>and</strong> with both devices were lower than 2% CV <strong>for</strong><br />
2 µl set volume with 384- <strong>and</strong> 1536-well microplates <strong>and</strong> about 1% CV with higher set volumes.<br />
215<br />
POSTER ABSTRACTS